
Last 4 earnings calls · through Q2 FY2026
The bull case starts with demand: grid storage and electric vehicles are consuming lithium faster than mines and converters can add supply, leaving inventories thin.
Management has taken out cost and capital permanently, so the same lithium price now produces far more profit and cash than it did two years ago.
Asset sales and cash generation have repaid debt, leaving room to fund growth from existing mines without new borrowing or share issuance.
The next leg of growth comes from expansions at mines the company already owns, which need little capital and start from a low cost position.
The bear case says Albemarle remains a price taker: profit still scales with lithium prices that Chinese traders and new mine supply decide, not with its own execution.
Sales volumes are flat this year and growth beyond depends on a plant that caught fire and on projects management has not yet approved for construction.
Converting spodumene into battery-grade chemicals outside China costs several dollars per kilogram more, which is why Western plants sit idle.
Reported cash flow includes a customer prepayment and inventory drawdowns that will not repeat, while idling a plant and Middle East supply costs absorb cash.
In short: Cost cuts and mine expansions are delivering, but 2026 volumes are flat and new projects are unapproved.
Higher stationary storage use supports more mine and conversion volume over the next decade, which is what underpins the expansion case for Greenbushes, Wodgina and the Salar.
The savings are mostly permanent operating changes rather than deferrals, so the same lithium price now yields a higher margin and more cash than before the program began.
CGP3 at Greenbushes and a third train at Wodgina raise output toward management's 2027 range of 240,000 to 260,000 tons LCE without building new plants.
Kings Mountain, the Salar de Atacama direct lithium extraction plant and further mine expansions are unapproved, so growth beyond 2027 is not yet committed or funded.
In short: Free cash flow and the balance sheet have improved sharply, but margins still swing with the lithium price.
Bromine pricing and cost work lifted the segment's full-year target at both the first-quarter and second-quarter updates, turning a business that was a drag into a contributor.
Free cash flow reached $1.3 billion over the last twelve months, 22.7% of revenue, versus negative free cash flow a year earlier, helped by halving capital spending.
Management's own scenario table shows margins lifting mainly as realized prices rise, so cost cuts alone do not protect earnings if lithium falls back toward prior lows.
Deferred revenue from a 2025 customer prepayment lifts reported earnings without adding cash, and placing Kemerton in care and maintenance consumes about $100 million this year.
In short: Lithium supply is tight and its mines are low cost, while China sets prices and Western conversion costs more.
With carbonate stocks under three weeks and hydroxide under a month, buyers have almost no buffer, which supports the price Albemarle is paid for its output.
Greenbushes, Wodgina, the Salar de Atacama and the Jordan bromine joint venture sit among the lower-cost sources of their products, which matters most when prices fall.
Chinese spot and futures benchmarks determine what Albemarle is paid, and Chinese converters hold the pricing power in the value chain between mine and battery.
Management puts the gap at roughly four to five dollars per kilogram, which is why the Kemerton hydroxide plant is idled and new Western capacity needs policy support to proceed.
Revenue fell 46.5% between FY2023 and FY2025 and operating margin went from 2.6% to negative 7.1%, showing how far results can fall when the lithium cycle turns.